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We have purified a 9 amino acid amidated neuropeptide, DPKQDFMRFamide, from whole adult
D. melanogaster. This peptide exhibits sequence homology to the molluscan bioactive tetrapeptide
FMRFamide and is a novel member of the FMRFamide peptide family. The gene encoding
DPKQDFMRFamide has been cloned and characterized. It is present in a single copy per haploid
genome, is expressed as a unique 1.7 kb mRNA species, and cytologically maps to 46C on the right
arm of chromosome 2. Characterization of a cDNA clone indicates that the precursor protein is 347
amino acids in length and contains 5 copies of DPKQDFMRFamide, as well as 10 additional amidated
peptides exhibiting varying degrees of structural relatedness. The Drosophila DPKQDFMRFamide gene
and the Aplysia FMRFamide gene are ancestrally related; however, peptides display a higher degree of
homology within a species than between species, suggesting intragenic concerted evolution of these
neuropeptides.
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ReflectionsDuring the 1980s, research in the Scheller laboratory at Stanford
University largely focused on the characterization of neuropep-
tide genes. In particular, we sought to define how these distinc-
tive signaling molecules are encoded in the genome, what spe-
cific neuropeptides are utilized by individual neurons, and how
these molecules regulate behavior. The experimental system of
choice was the docile and unassuming marine mollusk, Aplysia
californica. Aplysia are blessed with a relatively simple nervous
system, and many of its neurons are large and uniquely identifi-
able. Richard (Scheller) had initiated molecular studies of Aplysia
neuropeptides during postdoctoral studies at Columbia Univer-
sity. In particular, Scheller, Kandel, and Axel identified a small
family of genes expressed by the bag cell neurons and atrial
gland that encode multiple peptides that regulate egg-laying be-
haviors. The use of a novel differential cDNA screening approach
served as a powerful experimental paradigm, and additional neu-
ropeptide genes were soon identified from otherAplysia neurons.
John (Nambu) was Richard’s first graduate student and learned
about molecular biology and Aplysiology in the Scheller lab.
John’s thesis studies focused on the evolution of the egg-laying
hormone gene family. For these studies, we received live or fro-
zen tissue samples of various molluscan species from all around
the world. Despite what seemed like an obvious strategy, we
never went on any exotic collecting trips to pacific islands with
beautiful beaches—too much to do in the lab. This was the
dawn of molecular neurobiology, and, believe it or not, a debate
raged at the Society for Neuroscience meetings about whether
molecular biology would be of any use in learning about the brain.400 Neuron 60, November 6, 2008 ª2008 Elsevier Inc.While Aplysia proved to be an excellent system to identify neu-
ropeptide genes, this species was difficult to raise and not con-
ducive to genetic approaches. This limited the ability to analyze
neuropeptide gene function. In the laboratory next door, Corey
Goodman and colleagues were utilizing the fruit fly Drosophila
to analyze molecules controlling neuronal differentiation and
axonogenesis. John was in his fifth and, hopefully, final year of
graduate school, and Richard suggested that he try something
different. John asked him about attempting to study a neuropep-
tide gene in Drosophila. We agreed to give it a shot; it was a lab
policy to give students great latitude to pursue their own scien-
tific interests. And so began the adventure.
We choose the widely studied amidated tetrapeptide
FMRFamide as our entry point. Authentic FMRFamide had been
found only in mollusks, but related peptides were identified in
other invertebrates, and FMRFamide immunoreactivity was de-
tected in Drosophila. The Aplysia FMRFamide gene was first
characterized in Richard’s laboratory and shown to encode a
precursor containing an astounding 19 copies of the FMRFamide
peptide. Our strategy for Drosophila was first to biochemically
purify an FMRFamide-related peptide and then use the amino
acid sequence to isolate the corresponding gene. Mass quanti-
ties of flies were homogenized in methanol and the resulting
bright yellow concoction was concentrated in a rotary evapo-
rator and then subjected to sizing and ion exchange chro-
matography as well as HPLC. The presence of FMRFamide-im-
munoreactive material was assayed using a radioimmunoassay
to detect authentic FMRFamide as well as related peptides.
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ReflectionsUltimately, we somehow managed to end up with something
that looked reasonably pure, and we sent an unsettlingly large
portion of sample to Phil Andrews at Purdue University for
amino acid sequence analysis. At this point, one of us was
more than a little nervous—after all, John hadn’t graduated
yet. One afternoon John came back from lunch, and there
was a small piece of folded yellow paper on his desk. John
was told that it was a message from Phil and that he would
know what it meant. Indeed, that was the case when he opened
the note and all it said was DPKQDFMRFH2. It was the amino
acid sequence of the fly FMRFamide neuropeptide. Analysis
of cDNA clones led to the determination that the Drosophila
FMRFamide precursor is also quite complex, as it contained
five complete copies of DPKQDFMRFamide as well as ten re-
lated peptides. In an amazing example of synchronicity, Paul
Taghert’s laboratory at Washington University had simulta-
neously identified the Drosophila FMRFamide gene. Both Ri-
chard and Paul’s lab went on to explore the function and regu-
lation of this gene, and since then, many other neuropeptides
and their receptors have been characterized using Drosophila
molecular genetics. Indeed, such studies will be among theNeuron, March 1988, Volume 1, Issue 1
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Brain type II Ca2+/calmodulin-dependent protein kina
of three subunits, a (50 kd), b (60 kd), and b0 (58 kd
sequences of a (reported here) and b are highly sim
them is the deletion from a of two short segments
appear to encode b0 are identical to b except for the
Thus, the structural differences among a, b, and
a variable region lying immediately carboxyl to the p
a and b subunits are encoded by distinct genes exp
than being encoded by a third gene, b0 may arise by
In the two decades after the founding of Neuron, we witnessed
the unfolding of the ‘‘molecular biology revolution’’ and its culmi-
nation in the sequencing of individual genomes. Cloning of
cDNAs and rapid nucleotide sequencing were invented in the
early 1970s. By the mid-1980s, ‘‘cDNA-cloning’’ was all thetopics at an upcoming meeting on Insect Neuromodulators
and Neuropeptides at Janelia Farms.
In deciding where to submit our manuscript on Drosophila
FMRFamide, Richard noted that a brand new journal, Neuron,
was going to be published by Cell Press and focus on cellular
and molecular neurobiology. This presented a wonderful oppor-
tunity, and our work was published in the inaugural issue of
Neuron in March 1988. Over the last 20 years, Neuron has grown
to be the premier journal in neurobiology and published many of
the most important and influential papers in neuroscience.
Today, John is a tenured professor with his own lab, and Ri-
chard is Executive Vice President for Research and Chief Scien-
tific Officer at Genentech. Our lives have changed considerably
since the first issue of Neuron, but we will always be friends, hav-
ing shared the excitement and joy of scientific discovery.
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se is a holoenzymecomposed of several copies each
), in varying proportions. The deduced amino acid
ilar but not identical. The major difference between
(residues 316–339 and 354–392 in b). cDNAs that
deletion of a segment encoding residues 378–392.
b0 arise primarily from deletions (or insertions) in
rotein kinase and calmodulin-binding domains. The
ressed primarily, if not exclusively, in brain. Rather
alternative splicing of the b gene transcript.
rage. A new breed of ‘‘molecular neuroscientists’’ began cloning
and sequencing transcripts encoding neuronal receptors, ion
channels, and signaling enzymes. The wealth of molecular data
they generated set the stage for rigorous study of neuronal cell
biology.
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